New approaches to fat loss for class 1 obesity
Treatments studied
This study tests new methods to help people with mild obesity (class 1) lose fat. It aims to find more effective and safe ways to support weight loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 25 and 50 years old.
- You have a low risk of heart problems, as determined by a standard heart health score.
- You are willing to provide written consent to join the study.
- You do not have any heart rhythm problems or certain heart blocks.
- Your body mass index (BMI) is between 30 and 34.9, or you have normal weight and are part of a comparison group.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a gentle electrical stimulation to the ear can help people who haven't lost much weight with tirzepatide (a diabetes/weight drug). It's for people who are still overweight after 12 weeks of treatment.
This Phase 2 study tests whether tirzepatide can improve how your body handles fat (especially in people with overweight or obesity) and reduce fat-related “lipotoxicity.” It may help with body fat function and related health markers, but you must meet specific health and medication rules.
This trial tests an experimental drug called RN3161 to see if it helps with weight loss in people with overweight or obesity. It can be taken alone or with another weight-loss medication (tirzepatide).
This study tests whether combining a weight-loss medication called tirzepatide (also known as Mounjaro) with a supervised exercise program helps people lose weight and improve their overall health. You'll be in the study for about four months, and you'll get support and monitoring.
This study tests a new drug, NA-931, combined with an existing weight-loss medication (tirzepatide) to see if they work well and are safe for adults who are overweight or obese. It may help you lose weight and improve health conditions related to excess weight.
This study tests whether the medicine tirzepatide can help adults who are overweight or obese and have congenital heart disease (a heart condition present from birth) lose weight safely. The medicine may also improve heart health and metabolism. It is for people who have already tried diet and exercise for at least a year without much weight loss.
Hear when a new Class I Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.